Consort makes ‘logical’ £230m vertical integration move
This article was originally published in Clinica
Executive Summary
Drug delivery specialist Consort Medical has agreed to acquire fellow UK firm Aesica Pharmaceuticals for £230m ($373m), giving it a stronger foothold in the pharmaceutical supply chain. The move for the contract development and manufacturing organization (CDMO) is “logical,” according to Canaccord Genuity analyst Julie Simmonds, “giving the group a wider contract service offering.”